Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Pathogens (Basel, Switzerland)|August 23, 2020
The CMV-Specific CD8<sup>+</sup> T Cell Response Is Dominated by Supra-Public Clonotypes with High Generation ProbabilitiesKilian Schober, Pim Fuchs, Jonas Mir, et al.Plos One|February 20, 2015
Guanine-modified inhibitory oligonucleotides efficiently impair TLR7- and TLR9-mediated immune responses of human immune cellsFranziska Römmler, Monika Hammel, Anna Waldhuber, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 23, 2013
Guanine modification of inhibitory oligonucleotides potentiates their suppressive functionFranziska Römmler, Marion Jurk, Eugen Uhlmann, et al.Clinical & Translational Immunology|November 30, 2020
A T-cell reporter platform for high-throughput and reliable investigation of TCR function and biologyThomas R Müller, Corinna Schuler, Monika Hammel, et al.Immunity|May 10, 2023
Recruitment of epitope-specific T cell clones with a low-avidity threshold supports efficacy against mutational escape upon re-infectionAdrian Straub, Simon Grassmann, Sebastian Jarosch, et al.Proceedings of the National Academy of Sciences of the United States of America|February 28, 2023
Long-term persistence and functionality of adoptively transferred antigen-specific T cells with genetically ablated PD-1 expressionSarah Dötsch, Mortimer Svec, Kilian Schober, et al.Cell Reports. Medicine|July 19, 2023
Multimodal immune cell phenotyping in GI biopsies reveals microbiome-related T cell modulations in human GvHDSebastian Jarosch, Jan Köhlen, Sakhila Ghimire, et al.Science Immunology|August 12, 2022
Signatures of recent activation identify a circulating T cell compartment containing tumor-specific antigen receptors with high avidityAnna Purcarea, Sebastian Jarosch, Jack Barton, et al.Cell Reports. Medicine|September 1, 2021
Targeted T cell receptor gene editing provides predictable T cell product function for immunotherapyThomas R Müller, Sebastian Jarosch, Monika Hammel, et al.Nature Communications|April 10, 2026
Balancing the efficacy and safety of chimeric antigen receptor T-cell therapy by affinity combinationLinda Warmuth, Sarah Dötsch, Manuel Trebo, et al.Pageof 2